Clinical TrialsMepolizumab Improves Disease Control and Moves Patients Toward Remission in... Mepolizumab Improves Disease Control and Moves Patients Toward Remission in... Read Post »
Clinical TrialsCan Lower-Dose Aspirin Reduce Cancer Risk in People With Lynch Syndrome? Ca... Can Lower-Dose Aspirin Reduce Cancer Risk in People With Lynch Syndrome? Ca... Read Post »
Clinical TrialsPositive Phase 1 Findings Put AC Immune’s Brain-Penetrant NLRP3 Inhib... Positive Phase 1 Findings Put AC Immune’s Brain-Penetrant NLRP3 Inhib... Read Post »
Clinical TrialsLeads Biolabs’ LBL-024 (Opamtistomig) Shows 65% Response Rate in First-Li... Leads Biolabs’ LBL-024 (Opamtistomig) Shows 65% Response Rate in First-Li... Read Post »
New Drug ApprovalUltragenyx’s GENGLYCOS Receives FDA Accelerated Approval as First Treatme... Ultragenyx’s GENGLYCOS Receives FDA Accelerated Approval as First Treatme... Read Post »
New Drug ApprovalRegeneron Wins FDA Approval for Pasatru to Reduce New Bone Formation in Adu... Regeneron Wins FDA Approval for Pasatru to Reduce New Bone Formation in Adu... Read Post »
Clinical TrialsArcato’s Three-Anesthetic Cocktail Shows Safety and Early Analgesic Activ... Arcato’s Three-Anesthetic Cocktail Shows Safety and Early Analgesic Activ... Read Post »
Clinical TrialsModerna-Merck’s Intismeran Plus KEYTRUDA Shows Positive Phase 3 Resul... Moderna-Merck’s Intismeran Plus KEYTRUDA Shows Positive Phase 3 Resul... Read Post »
ResearchCan Risdiplam Sustain Survival and Motor Function in Children with Type 1 S... Can Risdiplam Sustain Survival and Motor Function in Children with Type 1 S... Read Post »
Clinical TrialsCould Once-Weekly IcoSema Offer a New Approach to Insulin Treatment in Type... Could Once-Weekly IcoSema Offer a New Approach to Insulin Treatment in Type... Read Post »
Clinical TrialsCan B7-H3-Targeted CAR-T Therapy Open a New Treatment Path for Recurrent Gl... Can B7-H3-Targeted CAR-T Therapy Open a New Treatment Path for Recurrent Gl... Read Post »
Clinical TrialsCan the Chemistry of Exercise Be Delivered in a Daily Pill? Enveda Advances... Can the Chemistry of Exercise Be Delivered in a Daily Pill? Enveda Advances... Read Post »
Clinical TrialsAvexitide Reduces Level 2 and Level 3 Hypoglycemic Events by 55% in Phase 3... Avexitide Reduces Level 2 and Level 3 Hypoglycemic Events by 55% in Phase 3... Read Post »
ResearchCan Dexamethasone Become a Noninvasive Option for Retinopathy of Prematurit... Can Dexamethasone Become a Noninvasive Option for Retinopathy of Prematurit... Read Post »
Clinical TrialsInnoCare Receives China Approval for Phase III Head-to-Head Mesutoclax Tria... InnoCare Receives China Approval for Phase III Head-to-Head Mesutoclax Tria... Read Post »
Clinical TrialsKRYSTAL-10: Adagrasib Plus Cetuximab Does Not Significantly Improve PFS or ... KRYSTAL-10: Adagrasib Plus Cetuximab Does Not Significantly Improve PFS or ... Read Post »
Clinical Trialsargenx Reports Positive Phase 3 ALKIVIA Results for Efgartigimod in Autoimm... argenx Reports Positive Phase 3 ALKIVIA Results for Efgartigimod in Autoimm... Read Post »
Clinical TrialsAstraZeneca Discontinues Phase III eVOLVE-Lung02 Trial of Volrustomig in Me... AstraZeneca Discontinues Phase III eVOLVE-Lung02 Trial of Volrustomig in Me... Read Post »
Clinical TrialsAstraZeneca and HUTCHMED Report Positive SAFFRON Phase III Results in MET-D... AstraZeneca and HUTCHMED Report Positive SAFFRON Phase III Results in MET-D... Read Post »
ResearchLong-Acting Broadly Neutralising Antibodies Delay HIV Viral Rebound After A... Long-Acting Broadly Neutralising Antibodies Delay HIV Viral Rebound After A... Read Post »
New Drug ApprovalFDA Approves TAUKLARIFY, Expanding Tau PET Imaging for Alzheimer’s Diseas... FDA Approves TAUKLARIFY, Expanding Tau PET Imaging for Alzheimer’s Diseas... Read Post »
Clinical TrialsSecukinumab Nearly Doubles Sustained Remission in Relapsed Polymyalgia Rheu... Secukinumab Nearly Doubles Sustained Remission in Relapsed Polymyalgia Rheu... Read Post »
Clinical TrialsArkBio’s Ziresovir Advances Into FDA-Cleared Phase II Trial in Critically... ArkBio’s Ziresovir Advances Into FDA-Cleared Phase II Trial in Critically... Read Post »
New Drug ApprovalBMS’s ZENBEXUS Becomes First FDA-Approved CELMoD for RRMM BMS’s ZENBEXUS Becomes First FDA-Approved CELMoD for RRMM Read Post »
New Drug ApprovalChina Approves Ivonescimab Combination for First-Line Squamous NSCLC China Approves Ivonescimab Combination for First-Line Squamous NSCLC Read Post »
Clinical TrialsClearmind Advances CMND-100 Trial into AUD After Positive Safety Review Clearmind Advances CMND-100 Trial into AUD After Positive Safety Review Read Post »
Clinical TrialsINGREZZA Improves Quality of Life and Daily Functioning in Phase 4 Tardive ... INGREZZA Improves Quality of Life and Daily Functioning in Phase 4 Tardive ... Read Post »
Clinical TrialsLecanemab in the Real World: Duke Study Reveals How Alzheimer’s Therapy P... Lecanemab in the Real World: Duke Study Reveals How Alzheimer’s Therapy P... Read Post »
Clinical TrialsNeOnc Reports 48.9% Six-Month PFS With NEO100 in IDH1-Mutant Glioma NeOnc Reports 48.9% Six-Month PFS With NEO100 in IDH1-Mutant Glioma Read Post »
Clinical TrialsREZILIENT3 Trial Shows PFS Benefit With Zipalertinib Plus Chemotherapy in N... REZILIENT3 Trial Shows PFS Benefit With Zipalertinib Plus Chemotherapy in N... Read Post »
Clinical TrialsLeap’s Sirexatamab Misses PFS Endpoint in mCRC but Shows Greater Benefit ... Leap’s Sirexatamab Misses PFS Endpoint in mCRC but Shows Greater Benefit ... Read Post »
New Drug ApprovalUK Becomes First European Country to Authorise Orforglipron UK Becomes First European Country to Authorise Orforglipron Read Post »
New Drug ApprovalEnhertu® Plus Pertuzumab Approved in China as First-Line Treatment for HER... Enhertu® Plus Pertuzumab Approved in China as First-Line Treatment for HER... Read Post »
Clinical TrialsBEL512 Shows Positive Phase 2 Results in CRSwNP, Supporting Potential for S... BEL512 Shows Positive Phase 2 Results in CRSwNP, Supporting Potential for S... Read Post »
Clinical TrialsJW Pharmaceutical’s Epaminurad 6 mg Shows Superiority Over Febuxostat... JW Pharmaceutical’s Epaminurad 6 mg Shows Superiority Over Febuxostat... Read Post »
ResearchAfter 10-Year Clinical Outcomes, Penn Medicine Study Finds CD19 CAR T Cells... After 10-Year Clinical Outcomes, Penn Medicine Study Finds CD19 CAR T Cells... Read Post »
Clinical TrialsShattuck’s SL-325 Advances to Phase 2b in Crohn’s Disease with Durable ... Shattuck’s SL-325 Advances to Phase 2b in Crohn’s Disease with Durable ... Read Post »
Clinical TrialsLZ901 Shows Strong Protection Against Herpes Zoster in Phase III Trial LZ901 Shows Strong Protection Against Herpes Zoster in Phase III Trial Read Post »
Clinical TrialsSilence’s Divesiran Meets Phase 2 Trial Endpoint in Polycythemia Vera Silence’s Divesiran Meets Phase 2 Trial Endpoint in Polycythemia Vera Read Post »
Clinical TrialsSonelokimab Delivers 42.1% ACR50 Response in Phase 3 Psoriatic Arthritis Tr... Sonelokimab Delivers 42.1% ACR50 Response in Phase 3 Psoriatic Arthritis Tr... Read Post »
Clinical TrialsTNX-103 Misses Primary Endpoint, Shows Benefit in More Severe PH-HFpEF TNX-103 Misses Primary Endpoint, Shows Benefit in More Severe PH-HFpEF Read Post »
Clinical TrialsAbCellera’s Phase 2 Data Position ABCL635 as a Potential New Approach to ... AbCellera’s Phase 2 Data Position ABCL635 as a Potential New Approach to ... Read Post »
ResearchInsilico Medicine Identifies NDRG1 as a New DNA Repair Target in Colorectal... Insilico Medicine Identifies NDRG1 as a New DNA Repair Target in Colorectal... Read Post »
New Drug ApprovalChina Approves Yochanra (Tinengotinib) for FGFR Inhibitor-Resistant Cholang... China Approves Yochanra (Tinengotinib) for FGFR Inhibitor-Resistant Cholang... Read Post »
Clinical TrialsAkeso Advances AK146D1 and Ivonescimab Combination in Breast Cancer Akeso Advances AK146D1 and Ivonescimab Combination in Breast Cancer Read Post »
Clinical TrialsBioMarin Stops BMN 401 Program After ENERGY 3 Trial Misses Key Endpoint BioMarin Stops BMN 401 Program After ENERGY 3 Trial Misses Key Endpoint Read Post »
ResearchHigh-Dose Vitamin D3 Does Not Improve Progression-Free Survival in Metastat... High-Dose Vitamin D3 Does Not Improve Progression-Free Survival in Metastat... Read Post »
New Drug ApprovalMHRA Authorises Rhapsido (Remibrutinib) for Adults with Chronic Spontaneous... MHRA Authorises Rhapsido (Remibrutinib) for Adults with Chronic Spontaneous... Read Post »
Clinical TrialsPepGen Advances PGN-EDODM1 in Phase 2 DM1 Trial After DSMB Review PepGen Advances PGN-EDODM1 in Phase 2 DM1 Trial After DSMB Review Read Post »
Drugs Safety AlertEuropean Commission Revokes TAVNEOS EU Approval for ANCA Vasculitis European Commission Revokes TAVNEOS EU Approval for ANCA Vasculitis Read Post »
